Gaddis Premier Wealth Advisors LLC acquired a new stake in shares of McKesson Corporation (NYSE:MCK – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 924 shares of the company’s stock, valued at approximately $800,000.
A number of other hedge funds also recently bought and sold shares of MCK. University of Texas Texas AM Investment Management Co. acquired a new position in shares of McKesson during the 4th quarter worth approximately $25,000. Swiss RE Ltd. purchased a new stake in shares of McKesson in the fourth quarter valued at approximately $26,000. State of Wyoming acquired a new stake in shares of McKesson in the second quarter valued at approximately $29,000. Board of the Pension Protection Fund acquired a new stake in shares of McKesson in the fourth quarter valued at approximately $33,000. Finally, Kingdom Financial Group LLC. purchased a new position in McKesson during the fourth quarter worth approximately $33,000. Institutional investors and hedge funds own 85.07% of the company’s stock.
McKesson Stock Performance
NYSE:MCK opened at $840.18 on Friday. The stock has a market capitalization of $98.37 billion, a P/E ratio of 21.84, a PEG ratio of 1.31 and a beta of 0.31. The company has a 50 day moving average price of $769.18 and a 200 day moving average price of $838.30. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00.
McKesson Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 1st. Investors of record on Monday, June 1st were given a $0.82 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is 8.53%.
Analyst Upgrades and Downgrades
MCK has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $875.00 price objective on shares of McKesson in a research note on Friday, May 8th. Wells Fargo & Company reduced their price target on McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 12th. William Blair assumed coverage on shares of McKesson in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. Citigroup lowered their price target on shares of McKesson from $975.00 to $945.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating for the company in a report on Friday, May 8th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $960.53.
Check Out Our Latest Stock Analysis on MCK
Insider Transactions at McKesson
In other news, CEO Brian S. Tyler sold 8,463 shares of the firm’s stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the transaction, the chief executive officer directly owned 5,919 shares in the company, valued at approximately $4,697,081.64. This trade represents a 58.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 133 shares of McKesson stock in a transaction on Friday, June 5th. The shares were sold at an average price of $764.00, for a total transaction of $101,612.00. Following the completion of the transaction, the chief accounting officer owned 632 shares in the company, valued at approximately $482,848. This represents a 17.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 28,748 shares of company stock valued at $22,262,035 over the last quarter. Company insiders own 0.06% of the company’s stock.
McKesson Company Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Read More
- Five stocks we like better than McKesson
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
